BIT's 18th Annual Congress of International Drug Discovery Science and Technology (IDDST-2023)
Program Committee

Advisory Board Members

Dr. Alexey Rak, Director of Bio Structure and Biophysics, Integrated Drug Discovery, Sanofi R&D, France

Dr. Amrik Basran, CSO, Avacta Life Sciences, UK

Dr. Angelito Jonas L. Kalaw, Medical Director, PAREXEL International, Australia

Dr. Anthony W. Coleman, Research Director, University of Lyon, France

Dr. Balázs Sarkadi, Professor, Research Centre for Natural Sciences, Institute of Enzymology, Hungarian Academy of Sciences, Hungary

Dr. David A. Boothman, Professor, Department of Biochemistry, Indiana University, USA

Dr. Emilia Barcia, Professor, University Complutense of Madrid, Spain

Dr. Florian Montel, Head of and CNS Project Leader in Medicinal Chemistry, Boehringer Ingelheim, Germany

Dr. Graham Ball, Professor of Bioinformatics/CSO, Nottingham Trent University/CompanDX, UK

Dr. Laurent Counillon, Professor, University of Nice-Sophia Antipolis, France

Dr. Loui Madakamutil, SVP, Head of Biology and Preclinical Development, Nektar Therapeutics, USA

Dr. Marian Paluch, Professor, University of Silesia, Poland

Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd., UK

Dr. Minying Cai, Professor, Department of Chemistry & Biochemistry, University of Arizona, USA

Dr. Natalie Pankova, Chief Operating Officer, Metadvice Ltd, UK

Dr. Ping Yang, CEO & Chairman, Synbio Technologies LLC, USA

Dr. Shanavaz Nasarabadi, President & Director R&D, GenTegra LLC, USA

Dr. William C. Maier, Chief Scientific Officer & Head, Rare Disease Research, Commercialisation and Outcomes Division, ICON Plc, UK

Dr. Yaakov Naparstek, Chairman of Medicine, Hadassah University Hospital, Israel

Dr. Yukio Yoneda, Invited Professor, Osaka University, Japan

© 2003-2023 All rights reserved by BITeomics
Contact Us:Tel:0086-411-84799609,